Treatment of chronic wounds of patients with diabetes mellitus using heterografts
DOI:
https://doi.org/10.15587/2519-4798.2020.213827Keywords:
diabetes, chronic wounds, limb ischemia, chronic venous insufficiency, heterograftAbstract
The aim. To investigate the reduction of wound healing time of various etiologies on the background of diabetes mellitus with arteries and veins with the help of combined treatment with the use of heterografts.
The article uses the results of treatment of 18 patients with chronic wounds of different etiology with diabetes which were treated in the department of vascular disease in “Institute of General and Emergency Surgery Named after V.T. Zaitsev NAMS of Ukraine” in 2019–2020 years. All patients had diabetes of II type, and 8 of them had III and IV level of limb ischemia according to Fontaine, and 7 of them had chronical venous insufficiency (CVI) C6 (according to CEAP), and 2 patients were diagnosed arterial and venous pathologies, one patient had vast chronic post-traumatic wound of a shin. All patients underwent analysis of clinical, laboratory, non-invasive and invasive methods of patients’ examination to determine the degree of the main blood flow disturbance, the nature of collateral blood circulation and microcirculation of the level of wound contamination, as well as the phase of the wound developing. Among the patients of the studied group with CVI, 2 patients underwent femoral shin shunting, 2 patients underwent hybrid reconstructive surgery, and 4 patients underwent endovascular interventions on the shin’s arteries. Patients with CVI underwent scleroobliteration of disabled perforators under ultrasound navigation. The patients were prescribed the following scheme: compensation of diabetes, metabolic therapy, antibacterial, anticoagulant and angiotropic therapy, physical therapy, local treatment: photodynamic therapy and staged closure of tissue defects by a heterograft membrane.
Results. The area of wounds surface in the patients with obliterating lesions of the arteries of the lower extremities before the start of treatment was in average of 391.3±100.42 cm2, against the background of complex treatment and wound closure with a heterograft on days 10–12 of treatment – 4.72±0.63 (p<0.01), and complete closure of the wounds was achieved within 3 weeks. In the patients with chronic venous insufficiency after performing sclerobliteration of incompetent perforants and PDT, the wound area was 16.92±0.18 cm2, on days 7–10 – 7.82±0.68 3 (by 50.63 %, p<0.01 ), and complete healing of the tissue defect was reached by the 4th week.
Conclusions. Use of a heterograft, namely the amniotic membrane makes it possible to achieve shorter periods of healing of chronic wounds in patients with diabetes mellitus. The healing is 2-3 times faster than other modern methods of treatment. It reduces cost of treatment and reduces the period of disability. Shorter treatment period also reduces workload on medical staff and improve the quality of life of patients with diabetes mellitus. Faster wound cleaning lowers risks of local infectious complications
References
- Aiubova, N. L., Bondarenko, O. N., Galstian, G. R. et. al. (2013). Osobennosti porazheniia prterii nizhnikh konechnostei i klinicheskie iskhody endovaskuliarnykh vmeschatelstv u bolnykh sakharnym diabetom s kriticheskoi ishemiei nizhnikh konechnostei i khronicheskoi bolezniu pochek. Sakharnii diabet, 4, 85–94.
- Ivanova, Y. V., Klimova, O. M., Prasol, V. O., Korobov, A. M., Mushenko, Y. V., Kiriienko, D. O., Didenko, S. М. (2018). Plastic closure of wounds in patients with ischemic form of diabetic foot syndrome. Medicni Perspektivi (Medical Perspectives), 23 (4 (1)), 71–75. doi: http://doi.org/10.26641/2307-0404.2018.4(part1).145669
- Zhadinskii, N. V., Zhadinskii, A. N. (2013). Pato- i sanogeneticheskie aspekty ranevogo protsessa (obzor literatury). Ukrainskii zhurnal khіrurgіi, 2 (21), 158–162.
- Klimova, E. M., Drozdova, L. A., Lavinskaia, E. V. et. al. (2015). Integralnaia metodologiia I.I. Mechnikova i sovremennaia adresnaia immunokorrektsiia pri miastenii. Annaly Mechnikovskogo instituta, 2, 30–36.
- Pityk, A. I., Prasol, V. A., Ivanova, Iu. V. et. al. (2018). Uriticheskaia ishemiia nizhnikh konechnostei. Sovremennye metody lecheniia. Kharkiv: Planeta-Print, 184.
- Rasmussen, T., Klauz, L., Tonnessen, B. (2010). Rukovodstvo po angiologii i flebologii. Moscow: Litterra, 560.
- Adler, A. I., Stevens, R. J., Neil, A., Stratton, I. M., Boulton, A. J. M., Holman, R. R. (2002). UKPDS 59: Hyperglycemia and Other Potentially Modifiable Risk Factors for Peripheral Vascular Disease in Type 2 Diabetes. Diabetes Care, 25 (5), 894–899. doi: http://doi.org/10.2337/diacare.25.5.894
- Oksuz, E., Malhan, S., Sonmez, B., Numanoglu Tekin, R. (2016). Cost of illness among patients with diabetic foot ulcer in Turkey. World Journal of Diabetes, 7(18), 462–469. doi: http://doi.org/10.4239/wjd.v7.i18.462
- Mottola, C., Semedo-Lemsaddek, T., Mendes, J. J., Melo-Cristino, J., Tavares, L., Cavaco-Silva, P., Oliveira, M. (2016). Molecular typing, virulence traits and antimicrobial resistance of diabetic foot staphylococci. Journal of Biomedical Science, 23 (1). doi: http://doi.org/10.1186/s12929-016-0250-7
- Svetukhin, A. M., Zemlianoi, A. B. (2012). Gnoino-nekroticheskie oslozhneniia sindroma diabeticheskoi stopy. Consilium Medicum, 4 (10).
- Pinto, N. R., Ubilla, M., Zamora, Y., Del Rio, V., Dohan Ehrenfest, D. M., Quirynen, M. (2017). Leucocyte- and platelet-rich fibrin (L-PRF) as a regenerative medicine strategy for the treatment of refractory leg ulcers: a prospective cohort study. Platelets, 29 (5), 468–475. doi: http://doi.org/10.1080/09537104.2017.1327654
- Saco, M., Howe, N., Nathoo, R., Cherpelis, B. (2016). Comparing the efficacies of alginate, foam, hydrocolloid, hydrofiber, and hydrogel dressings in the management of diabetic foot ulcers and venous leg ulcers: a systematic review and meta-analysis examining how to dress for success. Dermatology Online Journal, 22 (8). Available at: https://escholarship.org/uc/item/7ph5v17z
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Julia Ivanova, Vitaliy Prasol, Kyrylo Miasoiedov, Lyana Al Kanash
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
